Abstract

P2.11-24 Impact of Screening Interval Length on New Nodules Detected in Incidence Rounds of CT Lung Cancer Screening: the NELSON Trial

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
ES 02.01 The Dutch-Belgian Lung Cancer Screening Trial (NELSON)
H De Koning
Journal of Thoracic Oncology | VOL. 12
H De KoningH De Koning
01 Nov 2017
Lung cancer screening using low-dose computed tomography for high risk populations: Investigating effectiveness and screening program implementation considerations: An Evidence Check rapid review brokered by the Sax Institute (www.saxinstitute.org.au) for the Cancer Institute NSW
Nicole Rankin ... Anne Cust
-
Nicole Rankin, et. al.Nicole Rankin ... Anne Cust
01 Oct 2019
Detection of lung cancer through low-dose CT screening (NELSON): a prespecified analysis of screening test performance and interval cancers
Nanda Horeweg ... Harry J De Koning
Lancet Oncology | VOL. 15
Nanda Horeweg, et. al.Nanda Horeweg ... Harry J De Koning
01 Oct 2014
Lung cancer probability in patients with CT-detected pulmonary nodules: a prespecified analysis of data from the NELSON trial of low-dose CT screening
Nanda Horeweg ... Matthijs Oudkerk
Lancet Oncology | VOL. 15
Nanda Horeweg, et. al.Nanda Horeweg ... Matthijs Oudkerk
01 Oct 2014
View more papers

More From: Journal of Thoracic Oncology

Paper Title
Journal
Date
Author
From the IASLC Early Detection and Screening Committee Terminology Issues in Screening and Early Detection of Lung Cancer – IASLC Early Detection and Screening Committee Expert Group Recommendations
Rudolf M Huber ... Rudolf Huber
Journal of Thoracic Oncology | VOL. -
Rudolf M Huber, et. al.Rudolf M Huber ... Rudolf Huber
02 Aug 2024
Lung-MAP Next Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400)
David Kozono ... Mary W Redman
Journal of Thoracic Oncology | VOL. -
David Kozono, et. al.David Kozono ... Mary W Redman
01 Aug 2024
Real-World Acute Toxicity and 90-Day Mortality in Patients With Stage I NSCLC Treated With Stereotactic Body Radiotherapy
Peter S.N Van Rossum ... José S.A Belderbos
Journal of Thoracic Oncology | VOL. -
Peter S.N Van Rossum, et. al.Peter S.N Van Rossum ... José S.A Belderbos
25 Jul 2024
Analysis of Circulating Tumor DNA Predicts Outcomes of Short-Course Consolidation Immunotherapy in Unresectable Stage III NSCLC
Soyeong Jun ... Maximilian Diehn
Journal of Thoracic Oncology | VOL. -
Soyeong Jun, et. al.Soyeong Jun ... Maximilian Diehn
05 Jul 2024
View more papers